A multicenter, randomized, double-blind, placebo-controlled phase II trial was carried out by Aranow and associates (2015) [76] to determine if vitamin D supplementation reduces the interferon (IFN) signature in patients with systemic lupus erythematosus (SLE). This evidence concerns the gene IFNA1 and systemic lupus erythematosus.